NuVision Biotherapies secures £4.8m funding

Published on February 9, 2026
The company will use the funding to support its expansion overseas
Continue reading on website
Other news

Some red light therapy devices may exceed safety levels for myopia control, study suggests | Optometry Times - Clinical News

February 9, 2026
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Comanagement to take center stage at EnVision Summit 2026 | Optometry Times - Clinical News

February 9, 2026
Cecelia Koetting, the EnVision Summit chair for optometry, OD, FAAO, DipABO, gave a sneak peak into the CE and networking opportunities at the conference.